+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application


  • Publish date: 2018-09-11  | 
  • Pages: 114  | 
  • Tables: 141  | 
  • Hits: 3

  • Publish date: 2018-09-11  | 
  • Pages: 114
  • Tables: 141  | 
  • Hits: 3
Summary

This report studies the 23-Valent Pneumococcal Polysaccharide Vaccine market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.

The second place is EU, following North America with production market share of 15% and sales market share nearly 20% in 2015.China is another important market of 23-Valent Pneumococcal Polysaccharide Vaccine, enjoying 10% production market share and 15% sales market share in 2015.

The global 23-Valent Pneumococcal Polysaccharide Vaccine market was 1550 million US$ in 2017 and is expected to 4550 million US$ by the end of 2025, growing at a CAGR of 14.4% between 2018 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of 23-Valent Pneumococcal Polysaccharide Vaccine in these regions, from 2013 to 2025, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

    South America (Brazil etc.)

    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

    MSD

    Sanofipasteur

    CDIBP

By the product type, the market is primarily split into

    Single Dose Vial

    Pre-filled Syringe

By the end users/application, this report covers the following segments

    For Children (2-10)

    For Person (10-64)

    For The Old (≥65)

We can also provide the customized separate regional or country-level reports, for the following regions:

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

        Rest of Asia-Pacific

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

        Rest of Europe

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

        Rest of Middle East & Africa

The study objectives of this report are:

    To study and analyze the global 23-Valent Pneumococcal Polysaccharide Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of 23-Valent Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the 23-Valent Pneumococcal Polysaccharide Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of 23-Valent Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of 23-Valent Pneumococcal Polysaccharide Vaccine are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of 23-Valent Pneumococcal Polysaccharide Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of 23-Valent Pneumococcal Polysaccharide Vaccine market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Chemical manufacturers across the world have been supporting governments and have also been adhering to the rules and regulations made by respective authorities towards sustainable initiatives and green revolution. The developmental growth of bio-alternatives is also driving the growth of the chemical and material industry. Not only this, various academics and research institutes are cooperating with manufacturers across the world to develop sustainable alternatives for most common chemical substrates which are widely used in the globe.

Several companies are now eyeing further developments in green chemistry. Rapid shift towards environment-friendly chemicals is expected to gain impetus in the years to come after effectively made government regulations and preferences of end users. Increasing the cost of fossil fuels is also expected to drive the industry of chemical and material in a coming decade.

Reduction in the dependency on volume-driven growth can be seen due to increasing recycling practices which are impacting the sales of virgin materials. New materials that are available in the market are showing their potential for growth, however, chemical firms are yet to achieve a large amount of production of these materials along with high-quality maintenance.

Segmental Analysis

In market research, detailed segmentation of market plays the significant role. It classifies a large market into tiny parts based on various parameters. Apart from this, these segments are thoroughly evaluated on an individual basis and a team of analysts has ensured to give a crystal clear idea about various lucrative segments of the chemical and material industry. This detailed analysis of segmentation help in offering precise results about the markets related to chemical and material industry. While examining different segments of the markets in the chemical and material industry, the analysts in QY Research have carried out several surveys along with detailed primary research. To make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, the bottom-up approach has been used by the experts in the chemical and material industry.

Regional Analysis

This research report has presented various market segments with an in-depth analysis of key regions. Based on the regions the market is classified into the Middle East and Africa, Eastern & Western Europe, Latin America, the Asia Pacific including Japan and North America. The regional splits of the entire market along with its sub-segments are based on the use of the particular product in the respective regions or countries. The research analysts in QY Research went the extra mile to provide detail information about the scope of industries in countries such as the United States, Brazil, China, Japan, Malaysia, India and South Korea.

Revenue Share of Various Markets in Chemical and Material Industry

With the help of numerous primary interviews with experts and comprehensive secondary research, the team of analysts in QY Research have validated the data. In an attempt to provide a transparent scenario of the revenue share of the markets in the chemical and material industry to the present and potential clients, the research analysts in QY Research have done detailed product mapping of chemical and material manufacturers in the respective business segments of the company. An in-depth analysis of the breakdown of top vendors’ businesses into various segments under which they function has also provided in the reports related to chemical and material industry. Thus, annual revenue for each and every segment is also calculated and on the basis of secondary research and various company’s annual reports, evaluation and record of the entire annual revenue of the chemical and material manufacturers has been carried out effectively.

Competitive Landscape is the most valuable part of this report

Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market.  This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the chemical and material industry. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry. 


READ MORE
Table of Contents

1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview

    1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Overview

    1.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Type

        1.2.1 Single Dose Vial

        1.2.2 Pre-filled Syringe

    1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type

        1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth by Type

        1.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2013-2018)

        1.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2013-2018)

        1.3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2013-2018)

2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Company

    2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Company (2013-2018)

    2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Company (2013-2018)

    2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Company (2013-2018)

    2.4 Global Top Players 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Product Types

    2.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends

        2.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate

        2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 and Top 10 Players

        2.5.3 Mergers & Acquisitions, Expansion

3 23-Valent Pneumococcal Polysaccharide Vaccine Company Profiles and Sales Data

    3.1 MSD

        3.1.1 Company Basic Information, Manufacturing Base and Competitors

        3.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification

        3.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin(2013-2018)

        3.1.4 Main Business Overview

    3.2 Sanofipasteur

        3.2.1 Company Basic Information, Manufacturing Base and Competitors

        3.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification

        3.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin(2013-2018)

        3.2.4 Main Business Overview

    3.3 CDIBP

        3.3.1 Company Basic Information, Manufacturing Base and Competitors

        3.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification

        3.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin(2013-2018)

        3.3.4 Main Business Overview

4 23-Valent Pneumococcal Polysaccharide Vaccine Market Status and Outlook by Regions

    4.1 Global Market Status and Outlook by Regions

        4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and CAGR by Regions

        4.1.2 North America

        4.1.3 Asia-Pacific

        4.1.4 Europe

        4.1.5 South America

        4.1.6 Middle East and Africa

    4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue by Regions

        4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2013-2018)

        4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2013-2018)

        4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

    4.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin

        4.3.1 United States

        4.3.2 Canada

        4.3.3 Mexico

    4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin

        4.4.1 Germany

        4.4.2 UK

        4.4.3 France

        4.4.4 Italy

        4.4.5 Russia

        4.4.6 Turkey

    4.5 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin

        4.5.1 China

        4.5.2 Japan

        4.5.3 Korea

        4.5.4 Southeast Asia

            4.5.4.1 Indonesia

            4.5.4.2 Thailand

            4.5.4.3 Malaysia

            4.5.4.4 Philippines

            4.5.4.5 Vietnam

        4.5.5 India

        4.5.6 Australia

    4.6 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin

        4.6.1 Brazil

    4.7 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin

        4.7.1 Egypt

        4.7.2 GCC Countries

5 23-Valent Pneumococcal Polysaccharide Vaccine Application/End Users

    5.1 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application

        5.1.1 For Children (2-10)

        5.1.2 For Person (10-64)

        5.1.3 For The Old (≥65)

    5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Product Segment by Application

        5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

        5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application (2013-2018)

6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast

    6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2018-2025)

        6.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate Forecast (2018-2025)

        6.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2018-2025)

    6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions

        6.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2018-2025)

        6.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2018-2025)

        6.2.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2018-2025)

            6.2.3.1 China

            6.2.3.2 Japan

            6.2.3.3 Korea

            6.2.3.4 Southeast Asia

            6.2.3.5 India

            6.2.3.6 Australia

        6.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2018-2025)

        6.2.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2018-2025)

            6.2.5.1 Egypt

            6.2.5.2 GCC Countries

    6.3 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type

        6.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast by Type (2018-2025)

        6.3.2 Single Dose Vial Gowth Forecast

        6.3.3 Pre-filled Syringe Gowth Forecast

    6.4 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application

        6.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2018-2025)

        6.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast in For Children (2-10)

        6.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast in For Person (10-64)

7 23-Valent Pneumococcal Polysaccharide Vaccine Upstream Raw Materials

    7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials

        7.1.1 Key Raw Materials

        7.1.2 Key Raw Materials Price

        7.1.3 Raw Materials Key Suppliers

    7.2 Manufacturing Cost Structure

        7.2.1 Raw Materials

        7.2.2 Labor Cost

        7.2.3 Manufacturing Expenses

    7.3 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors

    8.1 Marketing Channel

        8.1.1 Direct Marketing

        8.1.2 Indirect Marketing

        8.1.3 Marketing Channel Development Trend

    8.2 Distributors

    8.3 Downstream Customers

9 Research Findings and Conclusion

Appendix

    Methodology/Research Approach

        Research Programs/Design

        Market Size Estimation

        Market Breakdown and Data Triangulation

    Data Source

        Secondary Sources

        Primary Sources

    Disclaimer

List of Tables and Figures

    Figure 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Status and Outlook (2013-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Status and Outlook (2013-2025)

    Figure Product Picture of Single Dose Vial

    Table Major Players of Single Dose Vial

    Figure Global Single Dose Vial Sales (K Dose) and Growth Rate (%)(2013-2018)

    Figure Product Picture of Pre-filled Syringe

    Table Major Players of Pre-filled Syringe

    Figure Global Pre-filled Syringe Sales (K Dose) and Growth Rate (%)(2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Comparison by Type

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share (%) by Type (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Type (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Type in 2017

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Type (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share (%) by Type (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share (%) by Type (2013-2018)

    Figure 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (%) by Type

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Type (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share (%) by Company (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share (%) by Company in 2017

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Company (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share (%) by Company (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share (%) by Company in 2017

    Table Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) by Company (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Top Players Manufacturing Base Distribution and Sales Area

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Top Players Product Category

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (%) of Top 5 Players

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (%) of Top 10 Players

    Table MSD Basic Information List

    Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification

    Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2013-2018)

    Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Global Market Share (%)(2013-2018)

    Table Sanofipasteur Basic Information List

    Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification

    Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2013-2018)

    Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Global Market Share (%)(2013-2018)

    Table CDIBP Basic Information List

    Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification

    Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2013-2018)

    Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Global Market Share (%)(2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Comparison by Regions (2013-2025)

    Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Regions (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Regions (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Regions (2013-2018)

    Figure 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Regions

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Regions (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (%) by Regions (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (%) by Regions (2013-2018)

    Figure 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (%) by Regions

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate

    Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate

    Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) (2013-2018)

    Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate

    Table Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate

    Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate

    Table Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure North Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure North Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose)(2013-2018)

    Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD)(2013-2018)

    Figure For Children (2-10) Examples

    Figure For Person (10-64) Examples

    Figure For The Old (≥65) Examples

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Comparison by Application (2013-2025)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2013-2018)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share (%) by Application (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Application (2013-2018)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) by Application in 2017

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Forecast by Regions (2018-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) Forecast by Regions (2018-2025)

    Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure North Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure North Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate (%) Forecast (2018-2025)

    Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Forecast by Type (2018-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (%) Forecast by Type (2018-2025)

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Forecast by Type (2018-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (%) Forecast by Type (2018-2025)

    Figure Single Dose Vial Sales Growth Forecast

    Figure Pre-filled Syringe Sales Growth Forecast

    Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Forecast by Application (2018-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2018-2025)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Forecast in For Children (2-10)

    Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Forecast in For Person (10-64)

    Table Key Raw Materials Lists

    Figure Key Raw Materials Price

    Table Raw Materials Key Suppliers Lists

    Figure 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Structure

    Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis

    Table Distributors List

    Table 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Customers

null
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>